This activity is intended for physicians, physician assistants, advanced practice nurses, general practitioners and other health care professionals involved in the treatment and management of patients who have or are at risk of HIV infection.
Upon completion of the program, participants should be able to:
Release Date: July 2, 2024
Expiration Date: July 2, 2025
Estimated time to complete the activity: 2 Hours
Media: Internet
Computer System Requirements: Internet Connection and Browser
 |
Richard A. Elion, MD Associate Professor of Clinical Medicine George Washington University Medical Center Washington, DC |
 |
Michelle Cespedes, MD Associate Professor of Medicine, Division of Infectious Diseases The Mount Sinai Hospital New York, New York |
 |
Aniruddha (Anu) Hazra, MD Assistant Professor, Section of Infectious Diseases and Global Health Medical Director, UCM Sexual Wellness Clinic Director of STI Services, Chicago Center of HIV Elimination Department of Medicine University of Chicago Chicago, Illinois |
 |
Helena Kwakwa, MD, MPH |
 |
In support of improving patient care, this activity has been planned and implemented by Partners for Advancing Clinical Education (PACE) and ViralEd, Inc. PACE is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team. |
PACE designates this enduring material for a maximum of 2.0 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
The maximum number of hours awarded for this Nursing Continuing Professional Development activity is 2.0 contact hours. Pharmacotherapy contact hours for Advanced Practice Registered Nurses will be designated on your certificate.
PACE designates this continuing medical education activity for 2.0 contact hour(s)(0.2 CEUs) of the Accreditation Council for Pharmacy Education.
Universal Activity Number: JA4008073-9999-24-135-H02-P
Type of Activity: Application
For Pharmacists: Upon successfully completing the activity evalutation, your credit will be submitted to CPE Monitor. Please check your NABP account within (30) days to make sure the credit has posted.
 |
PACE has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 2.0 AAPA Category 1 CME credits. Approval is valid until July 2, 2025. PAs should only claim credit commensurate with the extent of their participation. |
PACE requires every individual in a position to control educational content to disclose all financial relationships with ineligible companies that have occurred within the past 24 months. Ineligible companies are organizations whose primary business is producing, marketing, selling, re-selling or distributing healthcare products by or on patients.
All relevant financial relationships for anyone with the ability to control the content of this educational activity are listed below and have been mitigated according to PACE policies. Others involved in the planning of this activity have no financial relationships.
Michelle Cespedes, MD:
|
Helena Kwakwa, MD:
|
Richard Elion, MD:
|
Anu Hazra, MD:
|
The PIM planners and others have nothing to disclose.
To Claim Credit for this program, please go to: https://paceducation.com/HIVTxPrevention2024
For additional information about the accreditation of this activity, please visit: https://partnersed.com
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications.
The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient's conditions and possible contraindications on dangers in use, review of any applicable manufacturer's product information, and comparison with recommendations of other authorities.
This program requires HTML 5 enabled web browsers such as: Microsoft Edge, Mozilla Firefox, Apple Safari or Google Chrome.
An Independent CME Activity Jointly Provided by Partners for Advancing Clinical Education and ViralEd, Inc.
This activity is supported by independent educational grants from Gilead Sciences, Inc.
